ASTHO engaged Oklahoma public health officials, members of the Oklahoma Harm Reduction Alliance, Health Minds Policy Initiative, and representatives of the Southern Plains Tribal Health Board, and others in a Boundary Spanning Leadership ...
This video outlines a six-step process that health agencies can use when planning for viral hepatitis elimination.
Across the nation, public health agencies have mounted herculean efforts to stem the COVID-19 pandemic while addressing a pre-existing HIV epidemic and an opioid crisis that is serving as a source for many new HIV outbreaks. Tackling these ...
Jonathan Mermin of CDC discusses how using a syndemic approach could help health departments to address rising STI rates more effectively
Sexually transmitted diseases (STDs) are at a record high in the United States. In this episode, we hear state and national perspectives from leaders in the fight against STDs, discussing the resurgence and health impacts of STDs, proven ...
This episode discusses why there needs to be a comprehensive response in public health surveillance, in particular around the opioid epidemic. After all, without thorough data, it’s tough for lawmakers to drive action that will reduce the ...
In the Public Health Review podcast debut, host Robert Johnson speaks with public health officials from Alaska, Kentucky, and West Virginia about the ongoing opioid epidemic in the U.S. and its intersections with other epidemics like ...
State and territorial health leaders are thinking long-term about how policy changes made as a response to the pandemic might be continued to support vulnerable populations. During this episode, public health experts discuss how states and ...
March 24 is World TB Day, we have made significant progress in TB prevention, detection, and treatment. However, there is still a long way to go towards achieving TB elimination.
State Strategies for Advancing Viral Hepatitis Elimination astho, association of state and territorial health officials, public health officials, state health officials, territorial health officials, state health department, population ...
This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use drugs. New Mexico’s success in leveraging ...
In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights data-based approaches used to address four ...
In this episode, we explore Pennsylvania’s multi-pronged approach to addressing the opioid epidemic in the state and efforts to expand access to Medication Assisted Treatment.
This article in the Journal of Public Health Management and Practice addresses the syndemic of substance misuse, viral hepatitis, sexually transmitted infections, and mental health conditions. The technical package outlines evidence-based ...
The introduction of highly effective antiviral treatments for hepatitis C in 2014 marks the first time we have been able to cure a major and highly-infectious virus. Despite the significant challenges of addressing a highly stigmatized ...
Murray Penner, executive director of NASTAD, reflects on what it will take to end the global hepatitis epidemic and the critical role public health plays in accomplishing this important work.
In this wide-ranging conversation, Robert Redfield, MD, shares insights into how his own personal experiences have shaped his priorities as CDC director, the importance of improved communication around vaccine education, CDC’s strategy to ...
The second half of Public Health Review's story on the opioid epidemic explores how coalitions in Kentucky are driving prevention efforts, what public health practitioners in West Virginia are doing to identify and care for newborns ...
An analysis of CDC's 2022 update of its universal recommendation for the hepatitis B vaccine for adults.
In the background of the COVID-19 pandemic, cases of viral hepatitis continue to rise at alarming rates across the United States. Data from CDC highlights a 133% rise in cases of acute hepatitis C infection from 2012-2019 and new case ...